What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Virology, Coronavirus, Antibody, Gp41 and Peptide sequence.
Shibo Jiang interconnects Epitope, Middle East respiratory syndrome coronavirus and Immunogenicity in the investigation of issues within Virology.
His Coronavirus research includes themes of Nucleic acid amplification technique, Pneumonia, Receptor, Middle East respiratory syndrome and 2019-20 coronavirus outbreak.
In his work, Binding domain is strongly intertwined with Recombinant DNA, which is a subfield of Antibody.
His study in Gp41 is interdisciplinary in nature, drawing from both Viral envelope, Heptad repeat, Lipid bilayer fusion, Biochemistry and Viral entry.
His Peptide sequence study integrates concerns from other disciplines, such as Plasma protein binding, Binding site, Viral protein and Peptide.
His most cited work include:
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development (791 citations)
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. (672 citations)
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. (631 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Virology, Gp41, Antibody, Virus and Coronavirus.
His Virology study also includes fields such as
- Immunology which is related to area like Pandemic,
- Middle East respiratory syndrome coronavirus together with Middle East respiratory syndrome.
His Gp41 study combines topics in areas such as Heptad repeat, Lipid bilayer fusion and Biochemistry, Peptide.
His Antibody research integrates issues from Molecular biology and Antigen.
His research in Virus tackles topics such as Sexual transmission which are related to areas like Entry inhibitor.
His Coronavirus research incorporates elements of Outbreak, 2019-20 coronavirus outbreak, Protein subunit and Severe acute respiratory syndrome coronavirus 2.
He most often published in these fields:
- Virology (89.42%)
- Gp41 (37.08%)
- Antibody (33.33%)
What were the highlights of his more recent work (between 2017-2021)?
- Virology (89.42%)
- Antibody (33.33%)
- Severe acute respiratory syndrome coronavirus 2 (10.44%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Virology, Antibody, Severe acute respiratory syndrome coronavirus 2, Coronavirus and Virus.
His research in Virology intersects with topics in Spike Protein, Monoclonal antibody and Peptide.
The various areas that he examines in his Peptide study include Middle East respiratory syndrome coronavirus, Heptad repeat, Potency, Inhibitory postsynaptic potential and Enfuvirtide.
His studies deal with areas such as Gene, Immune system and Antigen as well as Antibody.
As a part of the same scientific study, Shibo Jiang usually deals with the Severe acute respiratory syndrome coronavirus 2, concentrating on Protein subunit and frequently concerns with Plasma membrane fusion.
His Coronavirus research focuses on Peptide sequence and how it relates to Plasma protein binding.
Between 2017 and 2021, his most popular works were:
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. (672 citations)
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. (631 citations)
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. (631 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus, 2019-20 coronavirus outbreak and Antibody.
His research in Virology is mostly focused on Lipid bilayer fusion.
He combines subjects such as Middle East respiratory syndrome coronavirus, Intensive care medicine, Severe acute respiratory syndrome coronavirus, Pandemic and Monoclonal antibody with his study of Severe acute respiratory syndrome coronavirus 2.
His Coronavirus study combines topics from a wide range of disciplines, such as Nucleic acid amplification technique, Virus, Betacoronavirus and Pneumonia.
His Antibody research is multidisciplinary, incorporating elements of In vivo and Binding site.
His Binding site research is multidisciplinary, incorporating perspectives in HEK 293 cells and Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
